^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BNT327

    i
    Other names: BNT327, PM8002, PM 8002, PM-8002, BNT 327, BNT-327
    Company:
    BioNTech
    Drug class:
    PD-L1 inhibitor, VEGF-A inhibitor
    Related drugs:
    Apply
    A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC (PM8002-B004C-TNBC-R) (NCT05918133)
    Phase 1/2
    Biotheus Inc.
    Recruiting
    Last update posted :
    12/03/2024
    Initiation :
    07/01/2022
    Primary completion :
    10/30/2026
    Completion :
    10/30/2026
    HER-2 • PGR
    |
    HER-2 negative • ER negative
    |
    albumin-bound paclitaxel • BNT327